Form 4 for NTRA Natera, Inc.
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-15 · accession 0001415889-24-008183 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-15 | 2024-03-15 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $88.96 | -83.2K | 260.3K | -24% | -$7.40M |
| DM | 2024-03-15 | 2024-03-15 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | $19.37 | +68.3K | 268.8K | +34% | +$1.32M |
| DM | 2024-03-15 | 2024-03-15 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | $0.00 | -68.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | S | D | 28,334 | $89.63 | 232,004 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. (F4) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.44 to $89.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-03-15 | S | D | 19,929 | $87.96 | 295,298 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.44 to $88.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-03-15 | M | A | 18,750 | $25.46 | 315,227 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-15 | M | A | 27,655 | $20.27 | 296,477 | D | — | — | |
| 5 | Common | Common Stock | 2024-03-15 | M | A | 21,865 | $13.01 | 268,822 | D | — | — | |
| 6 | Common | Common Stock | 2024-03-15 | S | D | 34,960 | $88.98 | 260,338 | D | — | — | (F1) The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.44 to $89.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option (right to buy) | 2024-03-15 | M | D | 27,655 | $0.00 | 3,595 | D | $20.27 · — to 2029-04-11 | 27,655 Common Stock | (F7) The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. |
| 8 | Derivative | Stock Option (right to buy) | 2024-03-15 | M | D | 21,865 | $0.00 | 2,084 | D | $13.01 · — to 2029-01-10 | 21,865 Common Stock | (F6) The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. |
| 9 | Derivative | Stock Option (right to buy) | 2024-03-15 | M | D | 18,750 | $0.00 | 0 | D | $25.46 · — to 2030-03-26 | 18,750 Common Stock | (F8) The option shares are fully exercisable. |